360° Coverage : What Are Bidis And Why Is The FDA Regulating Tobacco Products?

2 Updates

What Are Bidis And Why Is The FDA Regulating Tobacco Products?

Feb 25 2014, 8:53am CST | by

Last week, FDA’s Center for Tobacco Products issued their first regulatory action since being established by an act of Congress in 2009. An Indian company, Jash International, was instructed...

Filed under: news

 
 
 

30 weeks ago

What Are Bidis And Why Is The FDA Regulating Tobacco Products?

Feb 25 2014, 8:53am CST | by

Last week, FDA’s Center for Tobacco Products issued their first regulatory action since being established by an act of Congress in 2009. An Indian company, Jash International, was instructed to cease U.S. import, distribution, and sales of four brands of bidis, a tobacco smoking product that’s rolled in the leaves of the tendu plant, instead of paper, then tied with string. The specific bidi products are sold as Sutra Bidis Red, Sutra Bidis Menthol, Sutra Bidis Red Cone, and Sutra Bidis Menthol Cone.

An article in The Times of India suggests that Jash International is not a particularly well-known company in its home country, so this first FDA warning might be serving as a shakedown cruise for exercising their regulatory might. The company was cited for not registering their products with the FDA, an application that would likely have been turned down anyway since bidis do not meet the standards of having a “predicate product” sold in the U.S. as of February 15, 2007. What that means is that tobacco products sold as of that date serve as the standard to which new tobacco products are compared with for “substantial equivalence.”

The Act has been criticized in some circles as protecting the large tobacco manufacturers whose previously marketed products serve as such standards.

The FDA’s CTP order results from the authority provided under the Family Smoking Prevention and Tobacco Control Act of 2009, “to regulate the manufacture, distribution, and marketing of tobacco products to protect public health.”

Several local folks I spoke with were not aware that the FDA had regulatory authority of tobacco products, certainly not since 2009. A typical response is “Why would FDA regulate a potentially lethal product?” Indeed, use of tobacco products results in over 440,000 death per year in the U.S. alone.

In the briefest possible terms, the FDA Center for Tobacco Products takes a harm reduction approach to tobacco use in the U.S. The Act established the CTP’s mission as three-fold: 1) to prevent Americans—especially youth—from starting to use tobacco, 2) encourage current users to quit, and 3) decrease the harms of tobacco product use.

To accomplish this mission, the CTP has the authority to require tobacco companies to register their products with the FDA, disclose the content of the product, including nicotine and tar content, limit how tobacco is distributed and sold, and review new tobacco products before they are marketed. Of course, this is one activity where the FDA does not require proof of efficacy or safety. Rather, the products are being regulated to minimize their health risks for Americans who choose to continue smoking.

A major effort is directed at minimizing tobacco sales and promotion to minors, including a ban on all candy and fruit-type flavorings other than menthol. The special dispensation of menthol was a sticking point during legislative deliberations since its inclusion in cigarettes appeals disproportionate to minority groups and causes smoke to be inhaled more deeply into the lungs.

Interestingly, the Act only applies to manufactured or hand-rolled cigarettes, the tobacco used therein, and smokeless tobacco. Cigars do not fall under the Act, nor do the increasingly popular nicotine delivery devices, e-cigarettes.

However, a “Unified Agenda” statement from the FDA and the U.S. Department of Health and Human Services was published in Fall 2013 to give the CTP authority to regulate, “hookah, electronic cigarettes, cigars, pipe tobacco, other novel tobacco products, and future tobacco products.”

The Act represents the compromise from a long battle for complete prohibition of tobacco products that began with the FDA commissioner tenure of Dr. David Kessler from 1990 to 1997.

Kessler documents the history of tobacco regulation in a highly-readable and sometimes suspenseful 2002 book, “A Question of Intent: A Great American Battle With A Deadly Industry.” A Johns Hopkins-trained pediatrician with a University of Chicago law degree, Kessler was not new to politics. He had served as an advisor to Senator Orrin Hatch (R-Utah), who described him in 1991 as, “one of the brightest, most decent men I know.” Kessler had also taught food and drug law at Columbia.

Kessler is well-known to Forbes Pharma & Healthcare readers since his one of his major contributions was to accelerate the pace at which the FDA reviewed and approved pharmaceuticals. Among his accomplishment was to enable the agency to use surrogate endpoints of efficacy as the basis for approval of drugs to treat serious, life-threatening diseases. For example, an increase in CD4+ T lymphocytes was used as a surrogate marker of efficacy of HIV reverse transcriptase inhibitors instead of, say, five-year patient survival.

But Kessler also felt that if nicotine was a drug – which it is in pharmacological terms – and that the FDA regulates all chemicals that come in contact with our bodies, that the FDA should regulate tobacco products. While he was not successful at the time, his efforts carried on as social stigma to tobacco smoke grew across the U.S., even in tobacco-growing states like North Carolina (from where this post has been written).

Passage of the Family Smoking Prevention and Tobacco Control Act of 2009, garnered both bipartisan support, the endorsement of the American Cancer Society and American Heart Association, as well as the endorsement of major tobacco companies. The Act continues to raise concerns as to the ethics of a regulatory safety agency should continue to allow sales of products know to still be the leading cause of death in the United States.

But the Center for Tobacco Products also allows for training and development of policies in this arena. In fact, interested mid-career investigators might care to apply for the third class of FDA-CTP-Institute of Medicine fellowships in tobacco regulatory science. You have one week to send your application in – the deadline is March 3, 2014. Application information is here.

Source: Forbes Business

 
Update
2

4 weeks ago

Khazanah throws MAS RM6b lifeline

Aug 29 2014 5:01pm CDT | Source: Business Times Singapore

August 30, 2014 1:15 AMKHAZANAH Nasional will inject RM6 billion (SS$2.4 billion) over three years to resuscitate loss-making Malaysia Airlines (MAS) under a recovery plan that includes even an Act of Parliament. Other key moves are migrating its operations, assets and liabilities to a new company (NewCo) and slashing the workforce ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 
Update
1

4 weeks ago

MAS posts loss of RM307m for Q2

Aug 28 2014 5:00pm CDT | Source: Business Times Singapore

August 29, 2014 1:13 AMMALAYSIA Airlines (MAS) registered a loss of RM307 million (S$122 million) for the second quarter to end-June, but warned of worse to come in the second half when the "full financial impact of t ...
Source: Business Times Singapore   Full article at: Business Times Singapore
 

 

Don't miss ...

 

<a href="/latest_stories/all/all/30" rel="author">Forbes</a>
Forbes is among the most trusted resources for the world's business and investment leaders, providing them the uncompromising commentary, concise analysis, relevant tools and real-time reporting they need to succeed at work, profit from investing and have fun with the rewards of winning.

 

blog comments powered by Disqus

Latest stories

Rajdeep Sardesai of Headlines Today heckled in New York
New York, Sep 28 (IANS) Senior journalist Rajdeep Sardesai of Headlines Today news channel was heckled and roughed up, allegedly by a band of supporters of Indian Prime Minister Narendra Modi, outside the Madison Square Garden venue after he got a group of anti-Modi people to air their views just ahead of the prime minister's much-awaited speech to thousands of the Indian diaspora.
 
 
Breathe easy with 'Lung Flute'
New York, Sep 28 (IANS) An Indian-origin scientist has developed a hand-held "lung flute" that allows patients suffering from chronic obstructive pulmonary disease (COPD) to clear lung mucus simply by blowing into the respiratory device.
 
 
Millennials addicted to smartphones
New York, Sep 28 (IANS) The millennials are in awe of their smartphones, with nearly 90 percent admitting they never leave their devices during the day, says a new survey.
 
 
Facebook can steer young minds into politics
Sydney, Sep 28 (IANS) The Social networking site Facebook can encourage more young people to get engaged in politics, a new research shows.
 
 
 

Latest from the Network

Rajdeep Sardesai of Headlines Today heckled in New York
New York, Sep 28 (IANS) Senior journalist Rajdeep Sardesai of Headlines Today news channel was heckled and roughed up, allegedly by a band of supporters of Indian Prime Minister Narendra Modi, outside the Madison...
Read more on Ad Balla
 
Medals standings of 2014 Asian Games
Incheon, Sep 28 (IANS) China were on top of the medal standings of the 17th Asian Games after Day 9 with a total of 216 medals, including 105 golds. South Korea were in the second spot with 137 medals (42 golds) and...
Read more on Sport Balla
 
Indian medal winners at Incheon Asian Games
Incheon, Sep 28 (IANS) Following are the Indian medallists at the end of Day 9 of competitions at the 17th Asian Games here Sunday: Gold: Jitu Rai: Men's 50 metre pistol shooting Sandeep Kumar, Rajat Chauhan and...
Read more on Sport Balla
 
Asiad TT: Indian men and women bow out of team events
Incheon, Sep 28 (IANS) The Indian men's and women's table tennis teams suffered comprehensive defeats in their quarter-final matches at the Suwon Gymnasium here Sunday to exit from the 17th Asian Games. The men's team...
Read more on Sport Balla
 
Asiad: India eves take on South Korea in hockey semis
Incheon, Sep 28 (IANS) Riding on their inspiring 6-1 victory against Malaysia in their last pool A match, a confident Indian women's hockey team take on hosts South Korea in the semi-final of the 17th Asian Games at...
Read more on Sport Balla
 
Yogeshwar, Khushbir make it super Sunday for India (Roundup)
Incheon, Sep 28 (IANS) The Indian national anthem was Sunday played for the third time in two days as Yogeshwar Dutt ended the nation's 28-year-old wait for a gold medal from Asian Games wrestling while race walker...
Read more on Sport Balla
 
Benedict Cumberbatch not ready for Oscar talk
Benedict Cumberbatch insists it's too early to speculate whether or not he will win an Oscar. The 38-year-old star has received rave reviews for his portrayal of mathematician Alan Turing in 'The Imitation Game' but...
Read more on Movie Balla
 
Modi meets Nikki Haley
New York, Sep 28 (IANS) Prime Minister Narendra Modi Sunday met Indian American Governor of South Carolina Nikki Haley. Haley, one of the two Indian-American governors in the US, told the prime minister that she was "...
Read more on Politics Balla
 
Beyonce, Jay Z to document marriage problems?
Los Angeles, Sep 28 (IANS) Singer Beyoncé Knowles and her husband-rapper Jay Z will reportedly detail their recent marriage difficulties on their upcoming album. The couple's marriage was rumoured to be on the rocks...
Read more on Celebrity Balla
 
Paltrow's star-studded birthday bash
Los Angeles, Sep 28 (IANS) Actress Gwyneth Paltrow celebrated her first birthday since her split from husband Chris Martin by gathering her Hollywood friends for a dinner party here. The bash took place Friday night....
Read more on Celebrity Balla